Literature DB >> 27633282

Pathogenesis of Börjeson-Forssman-Lehmann syndrome: Insights from PHF6 function.

Arezu Jahani-Asl1, Cheng Cheng2, Chi Zhang2, Azad Bonni3.   

Abstract

Intellectual disability encompasses a large set of neurodevelopmental disorders of cognition that are more common in males than females. Although mutations in over 100 X-linked genes associated to intellectual disability have been identified, only a few X-linked intellectual disability proteins have been intensively studied. Hence, the molecular mechanisms underlying the majority of X-linked intellectual disability disorders remain poorly understood. A substantial fraction of X-linked intellectual disability genes encode nuclear proteins, suggesting that elucidating their functions in the regulation of transcription may provide novel insights into the pathogenesis of intellectual disability. Recent studies have uncovered mechanisms by which mutations of the gene encoding plant homeodomain (PHD)-like finger protein 6 (PHF6) contribute to the pathogenesis of the X-linked intellectual disability disorder Börjeson-Forssman-Lehmann syndrome (BFLS). PHF6 plays a critical role in the migration of neurons in the mouse cerebral cortex in vivo, and patient-specific mutations disrupt the ability of PHF6 to promote neuronal migration. Interestingly, PHF6 physically associates with the PAF1 transcriptional elongation complex and thereby drives neuronal migration in the cerebral cortex. PHF6 also interacts with the NuRD chromatin remodeling complex and with the nucleolar transcriptional regulator UBF, though the biological role of these interactions remains to be characterized. In other studies, PHF6 mRNA has been identified as the target of the microRNA miR-128 in the cerebral cortex, providing new insights into regulation of PHF6 function in neuronal migration. Importantly, deregulation of PHF6 function in neuronal migration triggers the formation of white matter heterotopias that harbor neuronal hyperexcitability, which may be relevant to the pathogenesis of intellectual disability and seizures in BFLS. Collectively, these studies are beginning to provide key insights into the molecular pathogenesis of BFLS.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Börjeson-Forssman-Lehmann syndrome; Heterotopia; Neuronal positioning; PAF1 complex; PHF6; Transcription; X-linked intellectual disability

Mesh:

Substances:

Year:  2016        PMID: 27633282      PMCID: PMC5102843          DOI: 10.1016/j.nbd.2016.09.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  95 in total

1.  1024C> T (R342X) is a recurrent PHF6 mutation also found in the original Börjeson-Forssman-Lehmann syndrome family.

Authors:  Karen M Lower; Göran Solders; Marie-Louise Bondeson; John Nelson; Arne Brun; Joanna Crawford; Gunilla Malm; Mats Börjeson; Gillian Turner; Michael Partington; Jozef Gécz
Journal:  Eur J Hum Genet       Date:  2004-10       Impact factor: 4.246

2.  The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucleosome remodeling activities.

Authors:  Y Zhang; G LeRoy; H P Seelig; W S Lane; D Reinberg
Journal:  Cell       Date:  1998-10-16       Impact factor: 41.582

3.  A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome.

Authors:  J Guy; B Hendrich; M Holmes; J E Martin; A Bird
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

4.  Disrupted-in-Schizophrenia-1 (Disc1) is necessary for migration of the pyramidal neurons during mouse hippocampal development.

Authors:  Kenji Tomita; Ken-ichiro Kubo; Kazuhiro Ishii; Kazunori Nakajima
Journal:  Hum Mol Genet       Date:  2011-05-03       Impact factor: 6.150

Review 5.  Understanding the molecular basis of fragile X syndrome.

Authors:  P Jin; S T Warren
Journal:  Hum Mol Genet       Date:  2000-04-12       Impact factor: 6.150

6.  A functional link between the histone demethylase PHF8 and the transcription factor ZNF711 in X-linked mental retardation.

Authors:  Daniela Kleine-Kohlbrecher; Jesper Christensen; Julien Vandamme; Iratxe Abarrategui; Mads Bak; Niels Tommerup; Xiaobing Shi; Or Gozani; Juri Rappsilber; Anna Elisabetta Salcini; Kristian Helin
Journal:  Mol Cell       Date:  2010-03-25       Impact factor: 17.970

7.  Behavioural phenotype in Börjeson-Forssman-Lehmann syndrome.

Authors:  C F de Winter; F van Dijk; J J Stolker; R C M Hennekam
Journal:  J Intellect Disabil Res       Date:  2009-02-02

8.  MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks.

Authors:  Lluis Morey; Carmen Brenner; Francesco Fazi; Raffaella Villa; Arantxa Gutierrez; Marcus Buschbeck; Clara Nervi; Saverio Minucci; Francois Fuks; Luciano Di Croce
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

9.  Role of GGF/neuregulin signaling in interactions between migrating neurons and radial glia in the developing cerebral cortex.

Authors:  E S Anton; M A Marchionni; K F Lee; P Rakic
Journal:  Development       Date:  1997-09       Impact factor: 6.868

10.  miR-128 regulates neuronal migration, outgrowth and intrinsic excitability via the intellectual disability gene Phf6.

Authors:  Eleonora Franzoni; Sam A Booker; Srinivas Parthasarathy; Frederick Rehfeld; Sabine Grosser; Swathi Srivatsa; Heiko R Fuchs; Victor Tarabykin; Imre Vida; F Gregory Wulczyn
Journal:  Elife       Date:  2015-01-03       Impact factor: 8.140

View more
  10 in total

Review 1.  Transcribing the connectome: roles for transcription factors and chromatin regulators in activity-dependent synapse development.

Authors:  Liang-Fu Chen; Allen S Zhou; Anne E West
Journal:  J Neurophysiol       Date:  2017-05-10       Impact factor: 2.714

Review 2.  Transcription Pause and Escape in Neurodevelopmental Disorders.

Authors:  Kristel N Eigenhuis; Hedda B Somsen; Debbie L C van den Berg
Journal:  Front Neurosci       Date:  2022-05-09       Impact factor: 5.152

3.  Genetic abnormalities in a large cohort of Coffin-Siris syndrome patients.

Authors:  Futoshi Sekiguchi; Yoshinori Tsurusaki; Nobuhiko Okamoto; Keng Wee Teik; Seiji Mizuno; Hiroshi Suzumura; Bertrand Isidor; Winnie Peitee Ong; Muzhirah Haniffa; Susan M White; Mari Matsuo; Kayoko Saito; Shubha Phadke; Tomoki Kosho; Patrick Yap; Manisha Goyal; Lorne A Clarke; Rani Sachdev; George McGillivray; Richard J Leventer; Chirag Patel; Takanori Yamagata; Hitoshi Osaka; Yoshiya Hisaeda; Hirofumi Ohashi; Kenji Shimizu; Keisuke Nagasaki; Junpei Hamada; Sumito Dateki; Takashi Sato; Yasutsugu Chinen; Tomonari Awaya; Takeo Kato; Kougoro Iwanaga; Masahiko Kawai; Takashi Matsuoka; Yoshikazu Shimoji; Tiong Yang Tan; Seema Kapoor; Nerine Gregersen; Massimiliano Rossi; Mathieu Marie-Laure; Lesley McGregor; Kimihiko Oishi; Lakshmi Mehta; Greta Gillies; Paul J Lockhart; Kate Pope; Anju Shukla; Katta Mohan Girisha; Ghada M H Abdel-Salam; David Mowat; David Coman; Ok Hwa Kim; Marie-Pierre Cordier; Kate Gibson; Jeff Milunsky; Jan Liebelt; Helen Cox; Salima El Chehadeh; Annick Toutain; Ken Saida; Hiromi Aoi; Gaku Minase; Naomi Tsuchida; Kazuhiro Iwama; Yuri Uchiyama; Toshifumi Suzuki; Kohei Hamanaka; Yoshiteru Azuma; Atsushi Fujita; Eri Imagawa; Eriko Koshimizu; Atsushi Takata; Satomi Mitsuhashi; Satoko Miyatake; Takeshi Mizuguchi; Noriko Miyake; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2019-09-17       Impact factor: 3.172

4.  Functional mapping of PHF6 complexes in chromatin remodeling, replication dynamics, and DNA repair.

Authors:  Silvia Alvarez; Ana C da Silva Almeida; Robert Albero; Mayukh Biswas; Angelica Barreto-Galvez; Thomas S Gunning; Anam Shaikh; Tomas Aparicio; Agnieszka Wendorff; Erich Piovan; Pieter Van Vlierberghe; Steven Gygi; Jean Gautier; Advaitha Madireddy; Adolfo A Ferrando
Journal:  Blood       Date:  2022-06-09       Impact factor: 25.476

5.  Characterization of a Mouse Model of Börjeson-Forssman-Lehmann Syndrome.

Authors:  Cheng Cheng; Pan-Yue Deng; Yoshiho Ikeuchi; Carla Yuede; Daofeng Li; Nicholas Rensing; Ju Huang; Dustin Baldridge; Susan E Maloney; Joseph D Dougherty; John Constantino; Arezu Jahani-Asl; Michael Wong; David F Wozniak; Ting Wang; Vitaly A Klyachko; Azad Bonni
Journal:  Cell Rep       Date:  2018-11-06       Impact factor: 9.423

6.  The influence of X chromosome variants on trait neuroticism.

Authors:  Michelle Luciano; Gail Davies; Kim M Summers; W David Hill; Caroline Hayward; David C Liewald; David J Porteous; Catharine R Gale; Andrew M McIntosh; Ian J Deary
Journal:  Mol Psychiatry       Date:  2019-03-06       Impact factor: 15.992

7.  X Chromosome Inactivation Pattern and Pregnancy Outcome of Female Carriers of Pathogenic Heterozygous X-Linked Deletions.

Authors:  Yuanyin Zhao; Jia Li; Limeng Dai; Yongyi Ma; Yun Bai; Hong Guo
Journal:  Front Genet       Date:  2021-12-17       Impact factor: 4.599

Review 8.  T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.

Authors:  Valentina Bardelli; Silvia Arniani; Valentina Pierini; Danika Di Giacomo; Tiziana Pierini; Paolo Gorello; Cristina Mecucci; Roberta La Starza
Journal:  Genes (Basel)       Date:  2021-07-23       Impact factor: 4.096

9.  PHF6 functions as a tumor suppressor by recruiting methyltransferase SUV39H1 to nucleolar region and offers a novel therapeutic target for PHF6-muntant leukemia.

Authors:  Hsiang-I Tsai; Yanping Wu; Rui Huang; Dandan Su; Yingyi Wu; Xiaoyan Liu; Linglu Wang; Zhanxue Xu; Yuxin Pang; Chong Sun; Chao He; Fan Shu; Haitao Zhu; Dongqing Wang; Fang Cheng; Laiqiang Huang; Hongbo Chen
Journal:  Acta Pharm Sin B       Date:  2021-10-30       Impact factor: 14.903

10.  Further characterization of Borjeson-Forssman-Lehmann syndrome in females due to de novo variants in PHF6.

Authors:  Céline B Gerber; Anna Fliedner; Oliver Bartsch; Siren Berland; Malin Dewenter; Marte Haug; Ian Hayes; Purificacion Marin-Reina; Paul R Mark; Francisco Martinez-Castellano; Isabelle Maystadt; Deniz Karadurmus; Katharina Steindl; Antje Wiesener; Markus Zweier; Heinrich Sticht; Christiane Zweier
Journal:  Clin Genet       Date:  2022-06-14       Impact factor: 4.296

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.